Well said. (Agree with all of it, though I'm not sure I would never sell, but we might have the decision made for us.)
Maybe we can turn the focus of the board to the positives. I'll list a few (in no particular order) and maybe we built on the list and hash them out.
1. Neurodegenerative Disease (Pona) 2. GIST 3. FGFR 4. The other 6 or so ISTs 5. '113 6. Molecule Next 7. EMA good decision 8. Better US Label 9. Good Sales numbers 10. Good news from Dr. Cortes 11. A good Japan deal
Most of these positives will take time. That's the hardest part. My favorites are 1, 3 and 6. Any hint of good news there is worth dollars in pps.
Market Data 
Markets 
AI
